Home
Suven Life Sciences Ltd Share Price History
Suven Life Sciences Ltd
NSE : 21 Feb, 2025
117.6-0.9 (-0.7%)
Prev Close
118.4
Open Price
118.4
Bid Price (QTY)
-
Offer Price (QTY)
-
Volume
499730
Today's High / Low
121.0 / 116.6
52 WK High / Low
169.3 / 82.9
Market Price of Suven Life Sciences Ltd
1M
1Y
3Y
5Y
Monitoring Suven Life Sciences Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.
History Market Price
| Date | Price | Open | High | Low |
|---|
Returns Comparison
1W
1M
3M
6M
1Y
3Y
5Y
10Y
Growth Parameters
| Parameter |  2017 |
|---|---|
| Sales (Cr.) | NaN |
| Sales YoY Gr. | - |
| Adj EPS | 6.85 |
| YoY Gr. | - |
| Net Profit (Cr.) | 87 |
| BVPS | 52.4 |
Key Financial Parameters
| Parameter | 2015 |
|---|---|
| Return on Capital Emp. % | 23.32 |
| Op. Profit Mgn % | 32.22 |
| Net Profit Mgn % | 20.85 |
| Debt to Equity % | 0.19 |
Latest Shareholding
Promoters Holdings Over Time
About Suven Life Sciences Ltd
- Suven Life Sciences Limited (Formerly known as Suven Pharmaceuticals Ltd) was incorporated in March, 1989.
- The Company changed its name from Suven Pharmaceuticals Limited to Suven Life Sciences Limited in September, 2003.
- Promoted by Sudharani Jasti and Venkateswarlu Jasti, the Company began operations in 1989 as specialty chemicals provider. The Company is a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of novel therapeutics for the treatment of neurodegenerative disorders.
- Suven has a wholly owned subsidiary, Suven Neurosciences, Inc., USA, focused on clinical development activities of Suven molecules from phase 2, Proof-of-Concept (POC) studies. The Company is in the business of Contract Research And Manufacturing Services (CRAMS), catering to the needs of global life science industry and fine chemical majors.
Popular Search
FAQs for Suven Life Sciences Ltd Share Price History
What are the key events that typically impact Suven Life Sciences Ltd's share price history?
Key events that impact Suven Life Sciences Ltd’s share price history include quarterly earnings releases, product launches, leadership changes, economic policies, and geopolitical developments.
How do stock splits affect Suven Life Sciences Ltd's share price history?
Stock splits reduce the nominal price of Suven Life Sciences Ltd's shares by increasing the number of outstanding shares, which typically makes the stock more accessible to a broader range of investors. Although the total market value of the company remains unchanged after the split, the split can affect investor perception and liquidity, potentially influencing the share price in the longer term.
How do dividends impact the share price history of Suven Life Sciences Ltd?
Dividends can influence Suven Life Sciences Ltd's share price history by typically causing a temporary dip on the ex-dividend date, as the stock price often adjusts to reflect the dividend payout. Over time, the impact of dividends on the share price may be offset by the company's overall financial performance and market conditions.
How do corporate announcements affect Suven Life Sciences Ltd’s share price history?
Corporate announcements such as mergers, acquisitions, or strategic shifts can lead to significant price changes. Any optimistic development news on Suven Life Sciences Ltd generally boosts the company’s share price, whereas negative news can lead to a decline in share price.
How can I use technical analysis to understand Suven Life Sciences Ltd’s share price history?
To understand Suven Life Sciences Ltd’s share price history using technical analysis, examine charts for patterns such as trends, support, and resistance levels, and apply indicators like moving averages or Relative Strength Index (RSI) to gauge potential future movements. Analyze historical data to identify recurring trends and signals that might suggest how the share price could behave under similar conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
